Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Abbott Laboratories

Start price
Target price
Perf. (%)
€103.36
19.09.22
€130.00
19.09.23
-8.59%
20.09.23

Could be worthwhile Investment >10% per year
High dividend yield expected
Revenue growth >5% per year expected
Top 10 in its market
buy
Amgen Inc.

Start price
Target price
Perf. (%)
€247.05
26.12.22
€255.00
26.12.23
-0.10%
19.09.23

Could be worthwhile Investment >10% per year
High dividend yield expected
positive Cash Flow expected
Good rating
buy
Amgen Inc.

Start price
Target price
Perf. (%)
€247.05
26.12.22
€255.00
26.12.23
-0.10%
19.09.23

Could be worthwhile Investment >10% per year
High dividend yield expected
positive Cash Flow expected
Good rating
buy
Amgen Inc.

Start price
Target price
Perf. (%)
€247.05
26.12.22
€255.00
26.12.23
-0.10%
19.09.23

Could be worthwhile Investment >10% per year
High dividend yield expected
positive Cash Flow expected
Good rating
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€555.50
15.09.23
€558.00
15.09.24
-3.96%
19.09.23

Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
buy
Booking Holdings Inc.

Start price
Target price
Perf. (%)
€2,112.5
14.01.23
€2,500.0
30.12.23
39.22%
18.09.23

Market Leader or Top 3
Well known brand
Very small cyclical dependencies
High challenges to pay loans and raise capital
buy
Booking Holdings Inc.

Start price
Target price
Perf. (%)
€2,112.5
14.01.23
€2,500.0
30.12.23
39.22%
18.09.23

Market Leader or Top 3
Well known brand
Very small cyclical dependencies
High challenges to pay loans and raise capital
buy
Booking Holdings Inc.

Start price
Target price
Perf. (%)
€2,112.5
14.01.23
€2,500.0
30.12.23
39.22%
18.09.23

Market Leader or Top 3
Well known brand
Very small cyclical dependencies
High challenges to pay loans and raise capital
Verizon Communications Inc.

Start price
Target price
Perf. (%)
€28.19
17.07.23
-
17.09.23
12.65%
17.09.23

Probably not worthwhile Investment
Revenue decline/stagnation expected
Risky balance sheet
Lower EBIT Margin than peer group
Verizon Communications Inc.

Start price
Target price
Perf. (%)
€28.19
17.07.23
-
17.09.23
12.65%
17.09.23

Probably not worthwhile Investment
Revenue decline/stagnation expected
Risky balance sheet
Lower EBIT Margin than peer group
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€64.59
16.09.22
-
16.09.23
9.92%
16.09.23

buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€64.59
16.09.22
-
16.09.23
9.92%
16.09.23

buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€64.59
16.09.22
-
16.09.23
9.92%
16.09.23

buy
Fortinet Inc.

Start price
Target price
Perf. (%)
€50.00
16.09.22
-
16.09.23
14.94%
16.09.23

buy
Fortinet Inc.

Start price
Target price
Perf. (%)
€50.00
16.09.22
-
16.09.23
14.94%
16.09.23

buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€309.00
15.09.22
€550.00
15.09.23
74.76%
16.09.23

buy
Altria Group Inc.

Start price
Target price
Perf. (%)
€42.00
15.09.22
-
15.09.23
-2.98%
16.09.23

Tesla Inc

Start price
Target price
Perf. (%)
€254.90
15.09.23
-
15.09.24
0.12%
15.09.23

Could be very worthwhile Investment >20% year
Tesla Inc

Start price
Target price
Perf. (%)
€254.90
15.09.23
-
15.09.24
0.12%
15.09.23

Could be very worthwhile Investment >20% year
Amazon.com Inc.

Start price
Target price
Perf. (%)
€131.82
15.09.23
-
15.09.24
0.18%
15.09.23

Could be worthwhile Investment >10% per year
Amazon.com Inc.

Start price
Target price
Perf. (%)
€131.82
15.09.23
-
15.09.24
0.18%
15.09.23

Could be worthwhile Investment >10% per year
Amazon.com Inc.

Start price
Target price
Perf. (%)
€131.82
15.09.23
-
15.09.24
0.18%
15.09.23

Could be worthwhile Investment >10% per year
buy
Air Products + Chemicals

Start price
Target price
Perf. (%)
€271.20
24.07.23
€275.00
24.07.24
6.01%
15.09.23

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
buy
Oracle Corp.

Start price
Target price
Perf. (%)
€76.51
13.09.22
€90.00
13.09.23
36.87%
14.09.23

buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€502.50
17.08.23
€510.00
17.08.24
10.75%
13.09.23

Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market